A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naïve Cancer Patients

PURPOSE: Combination therapy with aprepitant, serotonin receptor antagonist, and steroids improves the complete response rate of both acute and delayed chemotherapy-induced nausea and vomiting (CINV). However, it is not known whether ramosetron is suitable for administration in combination with apre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jang, Geundoo, Song, Hun Ho, Park, Keon Uk, Kim, Hyeong Su, Choi, Dae Ro, Kwon, Jung Hye, Kim, Ho Young, Han, Boram, Kim, Jung Han, Jung, Joo Young, Kim, Hyo Jung, Zang, Dae Young
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804728/
https://ncbi.nlm.nih.gov/pubmed/24155675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2013.45.3.172
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados